PAPER Hsieh S, Lillo P, Kiernan MC, Hodges JR, Mioshi E
SEARCH RESULTS
331008 RESULTS
PAPER Fricker M, Vilalta A, Tolkovsky AM, Brown GC
Caspase inhibitors protect neurons by enabling selective necroptosis of inflamed microglia.
J Biol Chem. 2013 Mar 29;288(13):9145-52. Epub 2013 Feb 5 PubMed: 23386613PAPER Alberio T, Bucci EM, Natale M, Bonino D, Di Giovanni M, Bottacchi E, Fasano M
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation.
J Proteomics. 2013 Feb 4; PubMed: 23385359PAPER Rahn KA, Watkins CC, Alt J, Rais R, Stathis M, Grishkan I, Crainiceau CM, Pomper MG, Rojas C, Pletnikov MV, Calabresi PA, Brandt J, Barker PB, Slusher BS, Kaplin AI
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20101-6. PubMed: 23169655PAPER Chen D, Zhu C, Wang X, Feng X, Pang S, Huang W, Hawley RG, Yan B
A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease.
Neurosci Lett. 2013 Mar 22;538:49-53. PubMed: 23384565PAPER Boswell CA, Mundo EE, Johnstone B, Ulufatu S, Schweiger MG, Bumbaca D, Fielder PJ, Prabhu S, Khawli LA
Vascular physiology and protein disposition in a preclinical model of neurodegeneration.
Mol Pharm. 2013 May 6;10(5):1514-21. PubMed: 23383983PAPER Kim SU, Lee HJ, Kim YB
Neural stem cell-based treatment for neurodegenerative diseases.
Neuropathology. 2013 Feb 5; PubMed: 23384285PAPER Gillette-Guyonnet S, Secher M, Vellas B
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.
Br J Clin Pharmacol. 2013 Mar;75(3):738-55. PubMed: 23384081PAPER Valera E, Masliah E
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies.
Pharmacol Ther. 2013 Jun;138(3):311-22. PubMed: 23384597PAPER González-Palau F, Franco M, Jiménez F, Parra E, Bernate M, Solis A
Clinical utility of the hopkins verbal test-revised for detecting Alzheimer's disease and mild cognitive impairment in spanish population.
Arch Clin Neuropsychol. 2013 May;28(3):245-53. PubMed: 23384601PAPER Golanska E, Sieruta M, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, Klich I, Mossakowska M, Szybinska A, Barcikowska M, Liberski PP
APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians.
Exp Gerontol. 2013 Apr;48(4):391-4. PubMed: 23384821PAPER Wozniak MA, Itzhaki RF
Intravenous immunoglobulin reduces beta amyloid and abnormal tau formation caused by herpes simplex virus type 1.
J Neuroimmunol. 2013 Apr 15;257(1-2):7-12. PubMed: 23385080PAPER Collin F, Sasaki I, Eury H, Faller P, Hureau C
Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease.
Chem Commun (Camb). 2013 Mar 14;49(21):2130-2. PubMed: 23386213PAPER Alper BJ, Schmidt WK
Evaluating amyloid Beta (aβ) 1-40 degradation by capillary electrophoresis.
Methods Mol Biol. 2013;984:263-73. PubMed: 23386350PAPER Christa Maree Stephan B, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
BMJ Open. 2013;3(2) PubMed: 23386579Current Filters
No filters selected